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The uptake of cholesterol from high-density lipoproteins (HDL) labeled with ‘*‘I and [3H]cholesterol was 
examined in cultured rat luteal cells. Luteal cells were incubated with labeled HDL, following which the 
metabolic fate of the apolipoproteins and cholesterol moieties of the receptor-bound HDL were examined. 
About 50% of the originally bound HDL apolipoproteins were released into the medium in 24 h by a 
temperature-dependent process while only 5% of the HDL cholesterol was released unmetabolized. Inclusion 
of unlabeled HDL in the chase incubation resulted in increased release of apolipoprotein-derived radioactive 
products without significant change in the release of unmetabolized cholesterol. 60% of the apolipoprotein- 
derived radioactivity could be precipitated with trichloroacetic acid; the remaining trichloroacetic acid-solu- 
ble radioactive fraction was identified as 1’251]iodotyrosine. Gel filtration chromatography of the chase-re- 
leased material showed that the trichloroacetic acid-precipitable products, which contained no detectable 
amounts of cholesterol, eluted over a range of molecular sizes (9430 kDa). No intact HDL was retroendocy- 
tosed. About 80% of trichloroacetic acid-precipitable products could be immunoadsorbed on anti- 
apolipoprotein A-I antibody immobilized on CNBr-activated Sepharose, suggesting the presence of frag- 
ments containing apolipoprotein A-I. This material was also capable of reassociating with native HDL. 
Lysosomal inhibitors were partially effective in inhibiting the amount of trichloroacetic acid-soluble products 
formed. The lysosomal degradation appeared to have no role in the uptake of HDL-derived cholesterol. 
These studies demonstrate preferential and total uptake of HDL cholesterol by luteal cells, with concomitant 
degradation of the lipoprotein. 
Introduction 
The role of plasma lipoproteins as a source 
cholesterol in ovarian cells has been a subject 
study by many laboratories, including ours [l-5]. 
Specific cell surface receptors have been identified 
for high- and low-density lipoproteins (HDL and 
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of 
LDL) in rat luteal cells [6,7] and both lipoproteins 
are equally effective in sustaining progesterone 
production [5]. However, important differences ex- 
ist in the binding characteristics and further 
processing of LDL and HDL. LDL binding re- 
quires Ca2 + and is sensitive to heparin and pro- 
teinase whereas binding of HDL is insensitive to 
heparin and proteinases, and has no known ionic 
requirements [6]. The processing of LDL appears 
to involve receptor-mediated endocytosis, fol- 
lowed by lysosomal degradation by a process simi- 
lar to that elucidated for the metabolism of this 
lipoprotein in cultured fibroblasts [S-lo]. Unlike 
LDL, the degradation of HDL to trichloroacetic 
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acid-soluble products occurs only to a small extent 
and the degradation does not account for all the 
HDL-derived cholesterol utilized for steroidogene- 
sis [11-13]. Disparities between degradation of 
HDL and the amount of steroids produced have 
also been observed in adrenocortical cells [14]. 
Preferential uptake of cholesterol ethers from re- 
constituted HDL by hepatocytes and adrenals have 
also been reported [l&16]. Thus, it appears that 
different cell types could take up cholesterol from 
HDL by a mechanism not involving degradation 
of the apohpoprotein. In the present study, we 
have addressed the question of HDL metabolism 
in rat luteal cells by examining the processing of 
apolipoproteins and HDL-derived cholesterol. The 
results show that r~eptor-bound HDL is intemal- 
ized by the luteal cells, and degraded HDL devoid 
of cholesterol is released as trichloroacetic acid- 
soluble and -insoluble products. 
Materials and Methods 
Materials 
Molecular weight standards and agarose gel 
(Bio-Gel A-OSm) were purchased from Bio-Rad 
Laboratories, Richmond, CA. Collagenase was the 
product of Cooper Biomedicals, MaIvem, PA, and 
McCoy’s medium was from GIBCO, Grand Is- 
land, NY. Bovine serum albumin (Fraction V), 
ovalbumin, dansylcadaverine and phenylmethyl- 
sulfonyl fluoride were obtained from Sigma 
Chemical Co., St. Louis, MO. Monospecific anti- 
human apolipoprotein A-I antibody was obtained 
from Boehringer-Mannheim Biochemicals, Indi- 
anapolis, IN, 3-iodotyrosine was from Aldrich 
Chemical Co., Milwaukee, WI, and 35-mm plastic 
tissue culture dishes were a product of Falcon 
Plastics, Oxnard, CA. Cyanogen bromide-activated 
Sepharose was from Pharmacia Fine Chemicals, 
Piscataway, NJ. [1,2,6,7-3H]Cholesterol (70 Ci/ 
mmol) and [l,2,6,7-3H]cholesteryl linoleate (75 
Ci/mmol) were from New England Nuclear, Bos- 
ton, MA. All other chemicals were purchased from 
Fisher Scientific Co., Detroit, MI. 
Animals and cell culture 
Luteal cell cultures were prepared from highly 
luteinized ovaries of 21-day-old Sprague-Dawley 
rats (Harlan Sprague-Dawley, Madison, WI) 
primed with pregnant mare serum gonadotropin 
and human chorionic gonadotropin (CG) as previ- 
ously described [12,13]. Each culture dish con- 
tained cells equivalent to 600-700 pg cellular pro- 
tein. Before conducting the experiments described 
here, the serum-supplemented medium was re- 
moved and the cells were washed three times with 
McCoy’s medium. 
Lipoproteins and labeling 
Human LDL (density, 1.02-1.063 g/ml) and 
HDL, (density, 1.125-1.21 g/ml) were isolated 
from plasma of healthy donors by sequential ul- 
tracentrifugation after density adjustment with 
KBr as described by Have1 et al. (171. The absence 
of apo~poprote~ E in the HDL was confirmed by 
SDS-polyacrylamide gel electrophoresis. HDL was 
labeled with 1251 by the iodine monochloride 
method of McFarlane [18], with some modifi- 
cations [6], to a specific activity of 300-500 
cpm/ng protein. Throughout this paper quantities 
of lipoproteins are expressed in terms of their 
protein content. Labeling with [3H]cholesterol was 
a~comp~shed by a modification of the procedure 
of Jonas et a1.‘[19] as follows. 2 ml of HDL in 0.15 
M NaCl(25 mg protein) were added to solvent-free 
~3H]cholesterol (5 &i) and incubated at 37 ‘C for 
3 h with occasional mixing. The product was 
mixed with 20 ml of density 1.21 KBr solution and 
centrifuged at 100000 X .g for 24 h. The top layer 
of labeled HDL was coIlected and dialyzed against 
three changes of 0.15 M NaCl/O.l mM EDTA 
(pH 7.3). The resulting labeled HDL was analyzed 
for cholesterol, cholesteryl esters and protein, 
which were found to be present in proportions 
similar to unlabeled HDL. Thin-layer chromatog- 
raphy showed that the label was exclusively on the 
unesterified cholesterol. On gel filtration using a 
10% agarose column the elution profile was super- 
imposable with that of unlabeled HDL. The 
specific activity of the labeled HDL was 14000 
cpm/pg of unesterified cholesterol (or, 1400 
cpm/pg of total cholesterol). 
[ 3H]Cholesteryl Iinoleate-labeled HDL was also 
prepared by the method described above using 10 
PCi of [ 3H]cholesteryl Iinoleate. The labeled HDL 
had a specific activity of 19000 cpm/pg of esteri- 
fied cholesterol (or, 16000 cpm/pg of total 
cholesterol). 
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Determination of HDL degradation 
Cultured luteal cells were preincubated with 10 
pg of ‘251-labeled HDL in 1 ml of McCoy’s 
medium at 37’ C for 3 h, unless otherwise stated. 
After removing the incubation medium, the cells 
were washed five times with 2-ml aliquots of Mc- 
Coy’s medium to remove unbound ‘251-labeled 
HDL. Further washing did not decrease the 
amount of cell-associated radioactivity. The cells 
were then incubated in 1 ml of McCoy’s medium 
for various time periods up to 24 h. This second 
incubation is referred to as ‘chase incubation’. At 
the time points indicated in tables and figures, the 
medium was aspirated and treated with 0.2 ml of 
2% bovine serum albumin (as a carrier), followed 
by 0.3 ml of 50% trichloroacetic acid (10% final 
concentration). After centrifugation at 3000 X g 
for 20 min, the pellet, representing larger peptides, 
was counted in a gamma counter. The supernatant 
was also counted to determine trichloroacetic 
acid-soluble radioactivity and then treated with 
KI/ H,O,, and extracted with chloroform/ 
methanol as described by Bierman et al. [20] to 
remove any inorganic iodide. The aqueous layer 
was counted to determine the amount of non- 
iodide trichloroacetic acid-soluble products. There 
was no detectable amount of radioactive iodine in 
the organic layer. The cells were dissolved in 1.5 
ml of 0.1 M NaOH by two extractions and the 
amount of cell-associated radioactivity was 
determined. 
In experiments using [ 3H]cholesterol-labeled 
HDL, the cells were preincubated with the labeled 
lipoprotein and then reincubated, as described 
above, for 24 h. The medium was collected and 
the cells were harvested and counted after adding 
scintillation fluid to determine the amount of 
cell-associated radioactivity. An aliquot of the 
incubation medium was assayed to determine the 
total amount of radioactivity released, and the 
remainder was extracted with petroleum ether and 
subjected to thin-layer chromatography as 
described [21]. The amount of sterols and pro- 
gestins in the incubation medium were calculated 
from the results. 
Gel filtration chromatography 
Luteal cell cultures were preincubated with 
‘251-labeled HDL and chased in 1 ml of McCoy’s 
medium for 24 h as described above. The incuba- 
tion medium was collected and chromatographed 
at room temperature on a 1.6 x 90 cm column of 
10% agarose equilibrated in a buffer containing 
0.15 M NaC1/0.3 mM EDTA/0.02% NaN,/O.l% 
ovalbumin (pH 7.5). The column was eluted with 
the same buffer and 2-ml fractions were collected. 
Ovalbumin was included in the buffer to maxi- 
mize recovery. Omission of ovalbumin from the 
buffer did not affect the elution pattern. The 
column was calibrated using molecular weight 
standards as well as native LDL and HDL. 
Paper chromatography 
Fractions comprising the low-molecular-weight 
peak (see Fig. 5) from the gel filtration chro- 
matography were combined and concentrated by 
lyophylization. The residue was dissolved in 0.5 
ml of water and subjected to paper chromatogra- 
phy on a 20 cm long strip of Whatman No. 1 filter 
paper using n-butanol/acetic acid/water (100 : 
22 : 50) as described [22]. An authentic sample of 
3-iodotyrosine was also chromatographed simulta- 
neously as standard. The amino acid spots were 
visualized by ninhydrin spray and radioactivity 
was localized by counting 3-mm slices of the chro- 
matogram. 
Immunoadsorption 
The amount of 1251-labeled apolipoprotein A-I 
present in the 24 h chase medium was quantitated 
by immunoadsorption to apolipoprotein A-I anti- 
body-Sepharose. The affinity matrix was prepared 
by conjugating the apolipoprotein A-I antibody to 
cyanogen bromide-activated Sepharose following 
the manufacturer’s instructions [23]. Prior to con- 
jugation, the antibody preparation had been ex- 
tensively dialyzed against the coupling buffer (0.1 
M NaHCOJ0.5 M NaCl, pH 8.3). The coupling 
procedure involved treatment of 1 g of the 
cyanogen bromide-activated Sepharose with 2 ml 
of the antiserum in 7 ml of coupling buffer for 90 
min, followed by blocking of the unoccupied sites 
on the matrix by incubating for 1 h in 0.1 M Tris 
buffer (pH 8). The antibody-Sepharose thus pre- 
pared was stored at 4O C as a suspension in equal 
volume of 0.1 M Tris-HCl buffer (pH 7.5) contain- 
ing 0.15 M NaCl. 500 ~1 of this suspension con- 
tained sufficient antibody to bind 5 pg of 1251- 
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labeled HDL. I~unoad~o~tion was carried out 
as follows. The antibody-Sepharose suspension 
(500 (~1) was poured into a vertically positioned 
disposable 2-ml syringe, the lower end of which 
was plugged with glass wool and connected to a 
peristaltic pump through a short length of Tygon 
tubing. After draining the buffer, 2 ml of the 24 h 
chase medium containing degraded i2*I-labeled 
HDL was added to the syringe and the eluate was 
recirculated using a peristaltic pump. After 30 min 
(by which time the adsorption was complete as 
determined in initial expe~ments), the recircu- 
lation was stopped and the eluate removed. The 
antibody-Sepharose was washed three times with 2 
ml portions of 0.1 M Tris buffer (pH 7.5). The 
amounts of radioa~ti~ty in the Sepharose, eiuate 
and washings were determined and the percentage 
of radioactivity bound to apolipoprotein A-I anti- 
body was calculated. 
Protein contents of samples were determined 
by the method of Lowry et al. 1241. Cholesteryl 
and cholesteryl esters were determined by the 
method of Deacon and Dawson 1251. 
The data were analyzed by analysis of variance 
and Duncan’s multiple range test. A value of 
P < 0.01 was considered significant. Values are 
also expressed as means j: SE. where indicated. 
Results 
metabolism of HDL u~~~~o~rotei~s by cuhmd 
luteal cells 
The initial experiments exa~ed the fate of 
labeled apolipoprotein following binding of 1251- 
labeled HDL to luteal cells. Luteal cell cultures 
were incubated with 10 gg of ‘%labeled NDL 
for 3 h, washed to remove the unbound i%labeled 
HDL and reincubated in the absence of lipopro- 
teins (chase). At 4, 18 and 24 h, the medium from 
triplicate dishes was removed and precipitated 
with 10% t~&hloroa~e~~ acid, and the cells were 
dissolved in 0.1 M NaOH. Cell-ass~iated, trichlo- 
roacetic acid-soluble and trichloroacetic acid-pre- 
cipitable radioactivities were determined in each 
case. The results (Fig. 1) show that the cells pro- 
gressively released radioactivity into the medium 
in such a way that by 24 h only about 50% of the 
o~~nally bound *B I-labeled HDL remained asso- 
ciated with the cells. At any time point during the 
chase incubation, 60-65% of the radioactivity pre- 
sent in the medium was precipitable with 10% 
trichloroacetic acid. Inclusion of 300-fold excess 
of unlabeled HDL in the incubation with 1251- 
labeled HDL inhibited the binding of ‘251-labeled 
HDL, and this was further reflected in the lower 
amounts of radioa~ti~ty released into the medium 
during the chase incubation period (Fig. 1). 
The possibility that the degradation of i*‘I- 
labeled HDL is due to nonspecific proteinases 
present in the incubation medium was examined 
by performing the above experiment in the pres- 
ence of phenylmeth~lsulfonyl fluoride, a pro- 
teinase inhibitor, The results (data not presented) 
showed that phenylmethylsulfonyl fluoride had no 
effect on the degradation of 1251-labeled HDL. 
The effect of incubation temperature on the 
release of cell-bound X3 I-labeled WDL is shown in 
Fig. 2. The initial incubation with ‘25f-labeled 
HDL was performed at 37” C and the chase was 
carried out at either 37 or 4 o C. Cells incubated at 
4OC released only 11% of the initially bound 
radioactivity in 24 h campared to 51% by the cells 
incubated at 37” C, indicating that the release of 
cell-bound radioactivity is an energy-dependent 
process. 
In the above experiments, the rate of release of 
lzsT radioactivity from cells containing receptor- 
bound ‘“f-labeled HDL is somewhat faster dur- 
ing the initial hours of chase incubation. To de- 
termine whether the mm-linearity of the rate of 
release is due to attainment of equilibrium be- 
tween released and dell-associated radioactive 
material, the experiment shown in Table I was 
carried out. In the control experiment (Table I, 
column A), three sets of luteal cell cultures in 
triplicate were incubated with 1251-labeled HDL 
and chased in the absence of lipoproteins. The 
incubations were terminated at 4, 18 or 24 h and 
the trichloroacetic acid-precipitable radioactivity 
in the medium was determined. Another set of 
triplicate dishes (Table I, column 3) was in- 
cubated with iz51-labeled HDL under similar con- 
ditions, chased in the absence of lipoproteins, and 
the chase medium was replaced at 4 and 18 h 
intervals with fresh medium. The trichloroacetic 
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Fig. 1. Release of receptor-bound ‘251-labeled HDL from luteal cells. Luteal cells were incubated with 10 pg/ml of 1251-labeled HDL 
in the absence (0) and presence (0) of a 300-fold excess of unlabeled HDL for 3 h, washed and reincubated in the absence of HDL. 
Cell-associated as well as trichloroacetic acid (TCA) -precipitable and trichloroacetic acid-soluble radioactivity in the medium were 
determined at the indicated time points. Values are means _+ SE. of triplicate determinations. 
was determined at 4, 18 and 24 h intervals. Ex- 
amination of data (Table I) revealed that replacing 
the incubation medium with fresh medium had no 
effect in the total amount of trichloroacetic acid- 
precipitable radioactivity released. The data indi- 
cate that the non-linearity of the release of trichlo- 
roacetic acid-precipitable radioactivity was not due 
to equilibration between radioactivity materials 
within the cells and in the medium. 
The effect of inclusion of unlabeled HDL in 
the chase medium on the release of cell-associated 
radioactivity is shown in Fig. 3 (upper panels). 
The cells were incubated with ‘251-labeled HDL 
for 3 h, washed and reincubated in the absence or 
presence of 10 pg of unlabeled HDL for periods 
up to 24 h. The results showed that the amount of 
trichloroacetic acid-precipitable radioactivity re- 
leased was higher when unlabeled HDL was pre- 
sent during the chase. The increase in trichloro- 
acetic acid-precipitable radioactivity was reflected 
in lower cell-associated and trichloroacetic acid- 
soluble radioactivity. Similar experiments using 
unlabeled LDL in the chase incubation medium 
(Fig. 3, middle panels) yielded slightly different 
results. The increase in the amount of trichloro- 
acetic acid-precipitable radioactivity was not as 
0 4 6 I2 I6 20 24 0 4 8 12 I6 20 24 
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Fig. 2. Effect of low temperature on the release of cell-associated 1251-labeled HDL. Luteal cells were incubated with ‘251-Iabeled 
HDL at 37 o C, chased in lipoprotein-free medium at either 37 (0) or 4’C (0) and cell-associated, trichloroacetic acid (TCA) 
-precipitable and trichloroacetic acid-soluble radioactivity were determined after the indicated time periods. Values are means+ S.E. 
of triplicate determinations. 
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Fig. 3. Effect of unlabeled HDL, LDL and human CG in the chase medium on the release of radioactir*ity from Meal cells 
containing receptor-bound ‘2SI-labeled HDL. Cells were incubated For 3 h with 10 Pg/mi ‘251-labeled HDL, washed and chased in 
the absence (~1) and presence (0) of the indicated concentrations of unlabeled HDL, LDL and human CC. Cell-associated, 
trichloroacetic acid (TCA)-precipitable and trichloroacetic acid-soluble radioactivity were determined at the indicated time points. 
Values are means + S.E. of triplicate determinations. * Significantly different from control, P -C 0.01. 
high as that obtained using unlabeled HDL, and, 
unlike HDL, there was an increase in the amount 
of trichloroacetic acid-soluble radioactivity. Inclu- 
sion of human CG in the chase incubation medium 
(Fig. 3, lower panels) had no detectable effect on 
the composition of the chase incubation medium. 
These results suggest that the presence of un- 
labeled HDL in the medium enhanced the 
processing of the lipoproteins, resulting in the 
release of a larger amount of radioactivity. 
Deter~nation of the effect of increasing 
amounts of unlabeled HDL in the chase medium 
on the release of radioactivity from cells initially 
labeled with ‘251-labeled HDL showed that the 
release of radioactivity increased in a concentra- 
tion-dependent manner (Table II). At the highest 
concentration of HDL used (200 pg), more than 
75% of the initially bound radioactivity was re- 
leased during the 24 h incubation, compared to 
less than 50% in the absence of HDL, and most of 
the increase was due to increase of trichloroacetic 
acid-precipitable products released. This experi- 
ment showed that the rate of processing of HDL 
in luteal cells is dependent on the concentration of 
HDL in the medium. 
Next, we exa~ned whether inhibitors of inter- 
nalization and lysosomal function had any effect 
on the release of cell-bound iz51-labeled HDL 
TABLE I TABLE II 
EFFECT OF REPLACING THE CHASE INCUBATION 
MEDIUM AT INTERVALS ON THE RELEASE OF TRI- 
CHLOROACETIC ACID-PRECIPITABLE RADIOACTIV- 
ITY INTO THE MEDIUM 
EFFECT OF UNLABELED HDL ON THE RELEASE OF 
RADIOACTIVITY FROM LUTEAL CELLS CON- 
TAINING RECEPTOR-BOUND ‘251-LABELED HDL 
Luteal cell cultures in triplicate were incubated with i2’I-labeled 
HDL for 3 h, washed and chased in HDL-free medium. In one 
set of dishes (column B), the medium was replaced with fresh 
medium at the indicated time points. The cumulative amounts 
of trichloroacetic acid-precipitable radioactivity released by the 
cells are shown in column B. Values in column A were ob- 
tained from three sets of triplicate dishes (one for each time 
point) which were incubated in the same chase medium 
throughout the incubation time (4, 8 or 24 h). Values are 
means + S.E. 
Luteal cells containing receptor-bound ‘251-labeled HDL were 
incubated with the indicated concentrations of unlabeled HDL 
for 24 h at 37 o C and the amount of trichloroacetic acid-pre- 
cipitable and trichloroacetic acid-soluble radioactivity in the 
medium were determined. Values are means + SE. of triplicate 
determinations. Values are expressed as a percent of the total 
cell-associated radioactivity at the beginning of the incubation. 
Chase incubation 
time (h) 
Total trichloroacetic acid-precipitable 
radioactivity released into the medium 
(ng/mg cell protein) 
A B 
4 43.9* 1.5 41.0& 1.4 
18 89.9k6.7 86.lk 0.4 









(Fig. 4). In this experiment, 50 PM dansylca- 
daverine, an inhibitor of receptor-mediated endo- 
cytosis, was included in the initial incubation of 
luteal cells with ‘251-labeled HDL, following which 
the cells were washed and chased for up to 24 h in 
the continued presence of the inhibitor. The in- 
hibitor had no effect on the amount of cell-bound, 
trichloroacetic acid-precipitable and trichloro- 
acetic acid-soluble radioactivity when compared 
to control, suggesting that receptor-mediated en- 
docytosis may not be involved in the metabolism 
of HDL in luteal cells. Similar experiments in the 
presence of 50 mM NH,Cl, an inhibitor of lyso- 
somal function, showed partial inhibition of the 
appearance of trichloroacetic acid-soluble radioac- 
tivity (Fig. 4) suggesting that at least a part of the 
degradation of ‘251-labeled HDL might take place 
in the lysosomes. Ammonium chloride did not 
affect the amount of cell-bound radioactivity dur- 
100 - 
I 1 I I I I 





24.2 + 1.6 19.1+ 1.2 
44.4kO.9 12.3 + 0.5 
52.1kl.l 11.0+0.9 
56.9rt4.5 12.1 kO.3 
61.0+ 3.4 12.OkO.4 
Y 
J I I I 1 I I 
I- 0 4 8 12 16 20 24 0 4 8 12 16 20 24 
CHASE INCUBATION TIME (hl 
Fig. 4. Effect of 50 gM dansylcadaverine (0) and 50 mM NH,Cl (A) on the release of receptor-bound “‘I-labeled HDL from luteal 
cells. Cells were incubated for 3 h with 1251-labeled HDL and chased for up to 24 h in lipoprotein-free medium. Inhibitors, when 
used, were present in both the incubations. Values are meansfS.E. of triplicate determinations. * Significantly different from 
control, P < 0.01. 0, control; TCA, trichloroacetic acid. 
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ing the 24 h of incubation. A slight increase in the 
amount of trichloroacetic acid-precipitable radio- 
activity, although consistently observed, was not 
statisti~~ly significant. Two other lysosomal in- 
hibitors, chloroquine (100 PM) and leupeptin (1 
mM), also partially inhibited the formation of 
trichloroacetic acid-soluble products. 
C~aracterizafio~ of ~~~~-lab~~ed HDL degradation 
products 
The nature of the radioactive products released 
during the chase period by luteal cells prein- 
cubated with ‘2sI-labeled HDL were analyzed by 
gel filtration chromatography. The chase medium 
containing radioactive products released by the 
cells was chromatographed on a 10% agarose col- 
umn (1.6 x 90 cm) equilibrated with buffer con- 
taining 0.1% ovalbumin and fractions of the eluate 
were analyzed for i2jI radioactivity. The sharp 
peak near the column total volume (Fig. 5) 
accounted for 41% of the total amount of radioac- 
tivity eluted from the column. The remainder of 
the radioactivity was eluted over a molecular size 
range of 9-80 kDa, but no intact ‘251-labeled 
HDL was present. Fractions comprising the Iow- 
molecular-wei~t peak (Fig. 5) were combined, 
concentrated by lyophylization and analyzed by 
paper chromatography. Greater than 96% of the 
radioactivity migrated as a single spot with RF 
0.62, which was identical to the R, value of an 
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Fig. 5. Gel filtration of chase-released ‘2sI-labeied HDL. The 
24 h chase medium containing radioactivity released by cells 
preincubated with tz5 I-labeled HDL was chromatographed on 
a 1.6 x 90 cm column of 10% agarose gel equilibrated with 0.3 
mM EDTA buffer (pH 7.5) containing 0.15 M NaCI, 0.02% 
NaN, and 0.1% ovalbumin and eluted with the same buffer. 
2-ml fractions were coilected and the radioactivity was de- 
termined 
As a control for the above experiment, 1251- 
labeled HDL was incubated for 24 h with ‘condi- 
tioned medium’ (medium recovered from luteal 
cell cultures incubated overnight in the absence of 
any additives) and subjected to gel filtration anal- 
ysis. The elution profile of the incubated HDL 
was similar to the starting HDL, showing that 
degradation had not occurred in the absence of 
cells (data not shown). 
In initial experiments in which ovalbumin was 
not included in the elution buffer, the recovery of 
radioactivity following agarose chromatography 
was 7580%. In an attempt to improve the re- 
covery, unlabeled HDL was mixed as a carrier 
with the test sample before subjecting to gel chro- 
matography. The addition of unlabeled HDL 
changed the elution pattern and most of the higher 
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Fig. 6. Effect of carrier unlabeled HDL on the elution profile 
of radioactivity released by luteal cells preincubated with l”I- 
labeled HDL. The 24 h chase medium containing released 
radioactivity was mixed with 200 pl of unlabeled HDL (upper 
panel) or unlabeled LDL (lower panel) and chromatographed 
on a 1.6X90 cm column of 10% agarose gel equilibrated with 
0.3 mM EDTA buffer (pH 7.5) containing 0.15 M NaCl, 0.02% 
NaN, and 0.1% ovalbumin and eluted with the same buffer. 
2-ml fractions were collected and the radioactivity was de- 
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molecular weight radioactive fragments co-eluted 
with the native HDL. Similar co-elution of radio- 
activity with native HDL occurred even when 
0.1% ovalbumin was present in the elution buffer 
(Fig. 6, upper panel). The [1251]iodotyrosine peak 
was unaffected by the presence of native HDL. 
The reassociation of 125 I-labeled HDL fragments 
with native HDL appears to be a specific process 
since use of unlabeled LDL as a carrier affected 
the elution profile only to a small extent (Fig. 6, 
lower panel). 
Further characterization of the nature of radio- 
active protein components released during the 
chase incubation of luteal cells containing recep- 
tor-bound ‘251-labeled HDL was carried out by 
immunoadsorption. On treatment of the 24 h chase 
medium with apolipoprotein A-I antibody-sep- 
harose (see Materials and Methods), 47% of the 
radioactivity was adsorbed by the antibody (Table 
III), suggesting that the medium contained frag- 
ments of HDL bearing intact apolipoprotein A-I. 
The incubation medium after treatment with 
apolipoprotein A-I antibody-Sepharose was sub- 
jected to trichloroacetic acid precipitation (Table 
TABLE III 
IMMUNOADSORPTION OF THE 24 h CHASE MEDIUM 
TO APOLIPOPROTEIN A-I ANTIBODY-SEPHAROSE 
In experiment 1, the 24 h chase incubation medium from luteal 
cells preincubated with ‘251-labeled HDL was subjected to 
immunoadsorption to apolipoprotein A-I antibody-Sepharose 
as described in Materials and Methods, and the unadsorbed 
material plus two washings were precipitated with 10% trichlo- 
roacetic acid. In experiment 2, the 24 h chase medium was 
directly precipitated with 10% trichloroacetic acid. Values are 
means k S.E. of triplicate determinations. 
w w 
Experiment 1 
total radioactivity in chase 
medium 12700+200 100+1.6 
adsorbed on apolipoprotein A-I 
antibody_Sepharose 5940+ 80 47 + 0.6 
trichloroacetic acid-precipitable 
in medium 1520* 40 12+0.3 
Experiment 2 
total radioactivity in chase 
medium 11430+190 100+1.7 
total trichloroacetic acid- 
precipitable 66305 90 58kO.8 
0 , 
40 60 80 iQ0 120 140 60 
ELUTION VOLUME (ml) 
Fig. 7. Chromatography of the 24 h chase medium from which 
immunoadsorbable materials have been removed by treatment 
with apolipoprotein A-I antibody-Sepharose. The chase 
medium after removal of immunoadsorbable materials was 
chromatographed on a 1.6 x 90 cm column of 10% agarose gel 
equilibrated with 0.3 mM EDTA buffer (pH 7.5) containing 
0.15 M NaCl, 0.02% NaN, and 0.1% ovalbumin and eluted 
with the same buffer. 2-ml fractions were collected and the 
radioactivity was determined. 
TABLE IV 
RELEASE OF APOLIPOPROTEINS AND CHOLESTEROL 
FROM CELLS PREINCUBATED WITH HDL 
Luteal cells preincubated with [3H]cholesterol- or 
[3H]cholesteryl linoleate-labeled HDL were chased for 24 h in 
the presence of O-200 ng of unlabeled HDL and the amount 
of radioactivity released into the medium was determined. 
Release of apolipoprotein degradation products was measured 
in parallel experiments in which the cells were preincubated 
with 1251-labeled HDL. The amounts of radioactive products 
released during the chase is expressed as a percentage of the 
initial cell-associated radioactivity at 0 h. Results are means + 
S.E. of triplicate determinations. 
Amount of Percent of originally Percent of the origi- 
unlabeled HDL bound HDL apolipo- nally bound HDL 
in chase (pg) proteins released a cholesterol released h 
Cells treated with [ 3 HIcholesterol-label4 HDL 
0 47*2 22+_1 
10 56&3 25k2 
50 63_+1 27k-1 
100 69f2 2353 
200 73f2 37_+2 
Cells treated with [ ‘Hlcholesteryl linoleate-labeled HDL 
0 46k3 21+1 
10 56+3 23+2 
50 65_+2 26k2 
100 70+3 27+1 
200 76k2 3453 
a Total radioactivity bound at 0 h = 460_+30 ng of HDL 
apolipoprotein. 
b Total radioactivity bound at 0 h = 180+ 15 ng of total HDL 
cholesterol. 
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III). The amount of radioactivity precipitated by 
trichloroacetic acid was 12% of that present in the 
original chase medium and represents radioactive 
peptides that did not bind to apolipoprotein A-I 
antibody-Sepharose. Direct trichloroacetic acid 
precipitation of the chase medium (before treat- 
ment with apolipoprotein A-I antibody-sep- 
harose) resulted in precipitation of 58% of the 
radioactivity (Table III), which is consistent with 
the total amount of peptides determined by im- 
munoadsorption (47%) followed by trichloroacetic 
acid precipitation (12%). 
Finally, the chase medium which had been 
subjected to immunoadsorption with apolipopro- 
tein A-I antibody-Sepharose was analyzed by 
agarose gel chromatography (Fig. 7). The small 
amount of trichloroacetic acid-precipitable 
peptides eluted over a wide range of molecular 
sizes, but were smaller fragments than the immu- 
noreactive fragments. These probably represent 
fragments containing apolipoproteins other than 
apolipoprotein A-I or partial degradation prod- 
ucts of the latter from which the antibody-recog- 
nizing moiety has been lost. These experiments 
show that HDL apolipoproteins are processed and 
partially degraded by the luteal cells. 
Metabolism of HDL cholesterol 
The metabolism of HDL-derived cholesterol in 
luteal cells was examined in experiments using 
HDL labeled with (1) [3H]cholesterol or (2) 
[ 3H]cholesteryl linoleate (Tables IV and V). Luteal 
cells pretreated with [ 3H]cholesterol-labeled HDL 
or [ ‘Hlcholesteryl linoleate-labeled HDL were in- 
cubated for 24 h in the presence of O-200 pg of 
unlabeled HDL. At the end of the incubation, 
radioactivity associated with the cells and in the 
medium was determined. The medium was also 
analyzed by thin-layer chromatography to de- 
termine the nature of the released radioactive 
products. Parallel experiments using cells pre- 
treated with iz51-labeled HDL also were con- 
ducted to determine the amount of apoli- 
poproteins released. Data presented in Table IV 
show that with increasing amounts of unlabeled 
HDL in the chase incubation, the release of 
apolipoprotein-derived radioactivity was in- 
creased. With the highest amount of unlabeled 
HDL used (200 pg) about 75% of the originally 
TABLE V 
COMPOSITION OF RADIOACTIVE PRODUCTS RE- 
LEASED BY LUTEAL CELLS PREINCUBATED WITH 
[ ‘HICHOLESTEROL-LABELED HDL 
Luteal cells preincubated with [3H]cholesterol- or 
[ 3 Hlcholesteryl linoleate-labeled HDL were chased for 24 h in 
the presence of O-200 pg of unlabeled HDL. The chase 
medium containing released radioactivity was analyzed by 
thin-layer chromatography as described in Materials and 
Methods. Numbers in parenthesis indicate percent of initially 
bound radioactivity released in total cholesterol and progestin 
fractions. 
Amount of Composition of radioactive products 
unlabeIedHDL released (ng/mg cell protein) 
in chase (pg) choles- choles- total progestins 
terol teryl cholesterol 
esters 
Cells treated with [3H]cholestero1-labeled HDL 
0 7.0 2.0 9.0 (5) 30.6 (17) 
10 9.0 1.8 10.8 (6) 34.2 (19) 
50 6.3 0.9 7.2 (4) 41.4 (23) 
100 7.1 1.4 9.1 (5) 32.4 (18) 
200 17.6 4.1 21.7 (12) 45.0 (25) 
Cells treated with [ 3H]cholesteryl linoleate-labeled HDL 
0 0.6 6.7 7.3 (4) 29.0 (17) 
10 0.9 4.1 5.0 (3) 35.3 (20) 
50 2.2 2.9 5.1 (3) 39.1 (23) 
100 5.0 6.3 11.3 (6) 36.5 (21) 
200 7.6 6.3 13.9 (5) 47.9 (29) 
bound 1251 label was released, compared to 50% in 
the absence of HDL. In comparison, the amount 
of cholesterol-derived radioactivity released dur- 
ing 24 h comprised only 21-37% of the originally 
bound label (Table IV). Analysis of the incubation 
medium by thin-layer chromatography (Table V) 
showed that 75-90% of the released radioactivity 
was in the form of progestins; the remainder was a 
mixture of labeled cholesterol and cholesteryl es- 
ters. Gel filtration analysis of the chase medium 
showed that all the radioactivity was eluted as a 
single peak near the column total volume (data 
not shown), indicating that the released cholesterol 
is not associated with the larger degradation prod- 
ucts of HDL. This experiment showed that both 
free cholesterol and cholesterol esters associated 
with HDL are utilized for steroidogenesis, and 
that concentration of HDL in the medium has 
moderate effects on the rate of processing of the 
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sterols. In summary, the results presented in Ta- 
bles IV and V indicate that HDL is intracellularly 
processed by luteal cells and the cholesterol is 
retained and utilized for steroidogenesis while the 
apoliprotein constituents are effluxed into the 
medium. 
Discussion 
The present studies have shown that HDL is 
intracellularly processed by luteal cells and that 
degradation of the HDL particle occurs during 
cholesterol uptake. The products of degradation of 
HDL appeared as both trichloroacetic acid-solu- 
ble and -precipitable fragments. Analysis of the 
chase medium by gel filtration showed that the 
higher-molecular-weight, trichloroacetic acid-pre- 
cipitable radioactive materials released by the cells 
eluted over a wide range of molecular sizes. The 
largest particles released had a particle size of 80 
kDa, which corresponds to less than one-third the 
size of the intact HDL used in this study. The 
absence of intact HDL in the medium suggests 
that retroendocytosis of HDL may not occur in 
these cells. However, 80% of the trichloroacetic 
acid-precipitable radioactivity was adsorbed by 
apolipoprotein A-I antibody-Sepharose. Since the 
peptides recognized by the antibody were eluted 
over a range of molecular sizes on gel filtration, it 
would be reasonable to assume that those frac- 
tions with a molecular size larger than apolipopro- 
tein A-I (i.e., 25-80 kDa) contain partially de- 
graded HDL particles. Interestingly, when the 
chase medium was mixed with carrier unlabeled 
HDL and subjected to gel filtration analysis, most 
of the radioactivity representing trichloroacetic 
acid-precipitable products co-eluted with the na- 
tive HDL. This reassociation appeared to be a 
specific process since use of LDL as a carrier did 
not result in similar co-elution. The results of this 
study are consistent with the idea that HDL 
delivers cholesterol to luteal cells without undergo- 
ing complete degradation to trichloroacetic acid- 
soluble products. A portion of the apolipopro- 
teins, either free or associated with a small amount 
of lipids, is released from the cell in immunologic- 
ally intact form. Under in vivo conditions the 
released material could interact with plasma lipo- 
proteins and reform into HDL particles. The abil- 
ity of the immunoprecipitable products in the 
chase medium to associate with native HDL sup- 
ports this contention. Preferential release of pro- 
tein-bound radioactivity and retention of lipid 
components in human aortic smooth muscle cells 
preincubated with ‘251-labeled lipoprotein (VLDL 
and LDL) has been reported by Filipovic and 
Buddecke [27]. About one-half of the released 
radioactivity was trichloroacetic acid-precipitable. 
These authors also found that bovine aortic smooth 
muscle cells labeled with ‘251-labeled HDL or 
‘251-labeled LDL released radioactivity into the 
medium, 35-40s of which was precipitable with 
specific anti-HDL and anti-LDL sera [28]. These 
observations are consistent with our results. 
The uptake of HDL appeared to be indepen- 
dent of internalization via coated pits since 
dansylcadaverine, a tranglutaminase inhibitor, had 
no effect on the release of radioactive products. 
Electron microscopic examination of the uptake of 
HDL in perfused rat ovary by Paavola and Strauss 
[29] also showed a lack of association of the label 
with bristle-coated areas of the plasma mem- 
branes. Lysosomotropic agents inhibited degrada- 
tion of ‘251-labeled HDL to trichloroacetic acid- 
soluble products, but had no detectable effect on 
the release of trichloroacetic acid-precipitable 
products. In this regard, Marshall [26] has found 
that retroendocytosis of insulin from adipocytes 
was unaffected by the lysosomal inhibitor chloro- 
quine, while inhibiting its degradation to trichlo- 
roacetic acid-soluble products. In our experiments, 
however, no intact HDL was detected in the in- 
cubation medium. It is not clear from the present 
studies as to which cellular compartments are 
involved in the preferential uptake of HDL 
cholesterol. 
When luteal cells containing receptor-bound 
‘25 I-labeled HDL were chased in medium contain- 
ing unlabeled HDL, the release of trichloroacetic 
acid-precipitable radioactivity consisting of par- 
tially degraded HDL was increased. A similar 
phenomenon was observed by Marshall [26] in the 
processing of insulin in adipocytes, where inclu- 
sion of unlabeled insulin in the chase incubation 
medium increased the retroendocytosis of cell- 
bound 1251-labeled insulin and reduced the levels 
of cellular and degraded ‘251-labeled insulin. The 
presence of unlabeled HDL in the medium may 
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stimulate the rate of internalization and processing 
of the receptor-bound *251-labeled HDL by the 
cell during the chase incubation. Since lysosomal 
degradation is not rapid enough to keep up with 
the influx of HDL, the partially degraded HDL is 
regurgitated faster. According to this mechanism, 
the uptake of HDL cholesterol by luteal cells is a 
rapid process, independent of lysosomal degrada- 
tion. 
Sedation of progesterone production in luteal 
cells by human CG increases cholesterol substrate 
utilization, and would be expected to increase 
lipoprotein uptake and degradation. When we 
tested this possibility by adding human CC to the 
chase incubation medium, no detectable effect of 
human CG on the composition of the radioactive 
products released was observed. It is possible that 
the cells have accumulated enough cholesterol dur- 
ing the initial incubation to sustain progesterone 
production at maximal levels, and increased 
steroidogenesis does not si~fic~tly deplete cel- 
lular cholesterol levels under the experimental 
conditions. 
Based on these studies, a model for HDL 
metabolism in luteal cells is proposed (Fig. 8). The 
initial phase is the binding of HDL particles to 
specific receptors on the luteal cell surface. Both 
apolipoproteins A-i and A-II have been shown to 
interact with the receptors [6]. The HDL particles 
are then internalized, although it appears that 
endocytosis via clathrin-coated pits is probably 
not involved. Once inside the cell, cholesterol and 
cholesteryi esters are taken up by a process not 
involving lysosomal degradation. The partially de- 






Fig. 8. Proposed mechanism of HDL metabolism in rat luteal 
CellS. 
from the cell or gets trapped in the lysosomal 
pathway and is completely degraded. Most of the 
HDL-derived cholesterol is either utilized for 
steroidogenesis or stored in the cell, while a small 
amount appears to be released into the medium, 
which is probably due to the bidirectional flux of 
cholesterol. Following the intracellular processing 
of HDL, the HDL receptor is likely to be re- 
cycled, ~thou~ expe~mental evidence is not 
available for this at the present time. 
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